Irving-headquartered McKesson, the provider of wholesale medical supplies, pharmaceutical distribution, and healthcare tech, has launched a new oncology-focused technology and insights business that’s designed to drive better outcomes for patients with cancer.
Called Ontada, the business arm will specifically support innovation, acceleration, and evidence generation to transform the fight against cancer. It will be part of the McKesson family—and represents the corporation’s dedication to using its capabilities and suite of technologies to help advance oncology care.
According to CEO Brian Tyler, McKesson remains committed to investing in the oncology community. In fact, the company has a long history in oncology.
Ontada is based on a core a core company belief: Precise insights, delivered at the point of need, can save more patients’ lives.
“As one of the largest healthcare companies, McKesson is at the center of care delivery, which provides a unique perspective on the complexities of cancer care and the growing needs among providers and life sciences companies,” Tyler said in a release. “With the launch of Ontada, we can now build upon our differentiated assets in oncology and deliver innovative solutions that help improve patient outcomes.”
McKesson’s technologies are already being deployed by The US Oncology Network and other community oncology providers, according to the company. That includes its iKnowMed electronic health record system and Clear Value Plus regimen support tool.
Tech, combined with real-world data and research used by global life sciences companies, will connect the full patient journey and power the future of cancer care.
McKesson’s ties with the national community oncology network runs deep within the organizations. Ontada, with its team of data scientists and oncology experts, plans to enable those collaborations with life sciences companies and oncology providers to leverage evidence-based data and insights that can accelerate innovation.
Overall, the goal is to deliver the best care possible and improve patient outcomes. The clinical benefits will be real, too: Ontada aims to help bring oncology products to market faster, expand the reach of therapies, and provide education opportunities to physicians.
Ontada will be run by its president, Derek Rago.
“At The US Oncology Network, we collaborate with practices to leverage evidence-driven care to deliver better patient outcomes,” Michael Seiden, president of The US Oncology Network, said in a statement. “We’re thrilled to have Ontada as a technology partner who shares our vision and will provide us with the tools and insights we need to put patients first.”
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
The gender gap in computing is getting worse: In 1995 37% of computer scientists were women, dropping to 24% today. State Farm is taking action with a new STEM summit to engage girls in science, technology, engineering, and math. Registration is open until Sept. 18.
-
With Dallas ranked as one of the top cities in America for tech pros, UT Dallas and Fullstack have launched four skills training bootcamps focused on coding, cybersecurity, data analytics, and DevOps. The online bootcamps begin in November with tuition at $11,995 each.
-
Last week, BUiLT International celebrated its one-year anniversary as a non-profit organization working to advance the representation and participation of Black people in tech. Peter Beasley, the founder of the organization, was voted back as Chairman of the Board for another year.
-
North Texas has plenty to see, hear, and watch. Here are our editors' picks. Plus, you'll find more selections to "save the date."
-
Women entrepreneurs—especially those in the tech world—have something to keep them warm at home Thursday during tomorrow's winter storm: The DEC Network’s inaugural, all-virtual Women X Tech event, from 11 a.m. to 4:30 p.m., is designed to help women founders from all tech industries connect, learn, and grow their businesses.
